Navigation Links
First study of Australia's high cost of pain reveals $34 billion price tag
Date:11/18/2007

For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion -- nearly $11,000 for each of the estimated 3.2 million people grappling with pain. The price tag of pain includes both financial costs and loss of healthy life.

The MBF Foundation study The High Price of Pain: The Economic Impact of Persistent Pain in Australia, conducted by Access Economics in collaboration with the University of Sydney Pain Management Research Institute also found that the people who are suffering from persistent pain are carrying more than half of its overall cost burden. The Foundation has called for pain to be treated as a health priority with a co-ordinated national response.

Findings from the study will be used to identify the best ways to ease suffering, save healthcare dollars and help patients maintain productive lives.

Dr Christine Bennett, MBF chief medical officer and chair of the MBF Foundation Steering Committee, said that establishing the economic cost of pain to Australia was a very significant development for healthcare strategy.

The impact and cost of persistent pain is so widespread that a national approach is needed to address this major health issue and its hidden health burden, Dr Bennett said. This is vital because pain is involved across a number of existing National Health Priority Areas such as cardiovascular disease, cancer, musculoskeletal disease and diabetes.

The study shows that the bottom line of chronic pain is huge both in human terms and its economic impact. Australians suffering from persistent pain could benefit from approaches that can help them manage or minimise their pain to improve their lives and the health system.

The studys expert advisory panel led by pain management pioneer Professor Michael Cousins AM, Dr Fiona Blyth at Sydneys Pain Management Research Institute found that:

  • 3.2 million people are living with pain and more women than men are affected
  • Productivity loss is $11.7 billion annually, or 34 per cent of total pain-related costs
  • The burden of disease accounts for a further third at $11.5 billion
  • Health system costs account for $7 billion, around 20 per cent of total pain-related costs

Professor Cousins said the study should prompt more action to prevent pain from going under-treated or untreated at all so that its economic cost can be reduced.

It is now possible to manage persistent pain in 70-80 per cent of patients yet fewer than 10 per cent actually obtain pain relief, said Professor Cousins.

Providing resources to deliver proper pain treatment has the potential to save Federal and State Governments enormous amounts of public funds. At least 50 per cent of patients who have access to effective treatment can return to a reasonable lifestyle, offering savings on hospital and doctor visits, x-rays, surgery and medications, not to mention improved productivity.

Dr Bennett said the landmark study would put pain on the health agenda. The MBF Foundation would be pursuing the next positive steps towards improving the lives of Australians living with chronic pain. These include:

  • Developing a coordinated National Plan for Pain;
  • Replacing ineffective stand alone therapies with effective multidisciplinary approaches, and
  • Providing education and awareness for health providers particularly in primary care


'/>"/>

Contact: Jackie Crossman
61-293-610-519
Research Australia
Source:Eurekalert

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: